Catheter Stabilization Devices Market (2025 - 2030) Size, Share, & Trends Analysis Report By Product (Arterial Securement Devices), By End Use (Hospitals, Home Healthcare Providers), By Region, And Segment Forecasts

Catheter Stabilization Devices Market Trends

The global catheter stabilization devices market size was estimated at USD 1.70 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2030. Factors such as increasing demand for minimally invasive surgeries; high prevalence of lifestyle diseases, such as cardiovascular diseases, renal failure, & cancer; increase in the number of surgeries that may require these devices for postoperative care; and an increase in the need to reduce catheter-associated complications & infections are expected to drive the market.

Aging also contributes to an increased need for these devices. The prevalence of urinary diseases, such as cystitis, urinary retention, urinary incontinence, benign prostate hyperplasia, and kidney stones, which lead to bladder dysfunction, is constantly increasing. The National Association for Continence states that around 25 million people in the U.S. suffer from some form of incontinence, which drives the demand for these devices. Thus, their growing use across various applications is anticipated to contribute to the increasing usage of stabilization devices.

Product Insights

Arterial securement devices dominated the catheter stabilization devices industry with the largest revenue share of 31.5% in 2024. This segment held the majority of the market share owing to the extensive use of arterial catheters in many surgeries associated with cardiovascular diseases and cancer therapies. The wide use of these devices makes securement important to reduce complications related to their use.

The CVC securement devices segment is expected to grow at the fastest CAGR of 6.3% over the forecast period. CVC securement is gaining importance owing to benefits such as the absence of interruptions during treatments, the need for a few repeat procedures and reinsertions, and a decrease in CVC replacement costs. An effective securement is crucial for critically ill patients requiring long-term therapy, such as in the case of cancer. According to WHO, in 2022, an estimated 20 million people were newly diagnosed with cancer, and approximately 9.7 million individuals died from cancer-related causes. Approximately 53.5 million people were alive within 5 years of cancer diagnosis. By 2050, the number of new cancer cases is projected to rise to over 35 million, marking a 77% increase from the 2022 estimate.

End Use Insights

Hospitals led the catheter stabilization devices industry, accounting for the largest revenue share in 2024. A high number of surgeries are performed in hospitals; therefore, catheters are widely used in hospitals for various kinds of treatments. The prevalence of infections associated with their usage is high in hospitalized patients. Catheter-associated Urinary Tract Infections (CAUTI) are the most commonly reported hospital-acquired infections, and their prevalence continues to increase. Between 1990 and 2021, the incidence of Urinary Tract Infections (UTIs) rose by 66.45%, reaching a total of 4.49 billion cases. The Age-Standardized Incidence Rate stood at 5,531.88 per 100,000 people. Women and older adult men were found to have the highest rates of UTI. In addition, tropical Latin America and regions with low to middle socio-demographic index reported the highest prevalence of UTIs. As a result, there is a growing need for safer, more secure catheter stabilization devices to help reduce the risk of infections. 

The home healthcare providers segment is expected to grow significantly over the forecast period. Urinary catheters are also used at home for incontinence, retention, and post-surgical care. In the U.S., 53% of homebound older adults and up to 45% of women, including 7% to 37% of women aged 20 to 39, experience urinary incontinence. This growing prevalence drives the demand for catheter stabilization devices among home healthcare providers, as they help ensure secure placement, reduce complications, and enhance the quality of home-based care.

Regional Insights

The North American catheter stabilization devices market dominated the global market, with a 36.6% revenue share in 2024. This region's large share can be attributed to the high number of surgeries, which drives the demand for stabilization devices. According to a CIHI report, surgical volumes in Canada rose to 2.33 million in 2023-2024, an increase of 5% compared to 2019-2020. The wide adoption of catheterization techniques in examination, diagnosis, and treatment is also one of the factors responsible for market growth. Increasing usage of intravascular catheters in this region is further anticipated to drive the market.

U.S. Catheter Stabilization Devices Market Trends

The U.S. catheter stabilization devices market led North America with the largest revenue share in 2024. The Joint Commission, in its monograph, “A Global Challenge, A Global Perspective,” states that an estimated 80,000 Central Line-Associated Bloodstream Infections (CLABSIs) occur in ICUs each year in the U.S. The number increases to 250,000 cases of CLABSIs each year if patients outside the ICUs are included as well. Up to 28,000 patients die each year from CLABSI in ICUs across the U.S. The increasing prevalence of such infections is one of the key factors driving the need for their proper and effective securement.

Europe Catheter Stabilization Devices Market Trends

The Europe catheter stabilization devices market held a substantial share of the industry in 2024. The growing number of dialysis patients, especially those choosing home hemodialysis, along with the rising prevalence of chronic conditions such as cardiovascular and urinary diseases, drives market demand. In 2024, an estimated 7.2 million people in the UK were affected by Chronic Kidney Disease (CKD) stages 1-5. Of these, approximately 3.25 million were in the more advanced stages (3-5), where symptoms become increasingly challenging to manage. This trend highlights the urgent need for effective treatment options and supportive medical devices.

Asia Pacific Catheter Stabilization Devices Market Trends

The Asia Pacific catheter stabilization devices market is expected to grow at the fastest CAGR of 6.3% over the forecast period. The aging population, improving healthcare infrastructure, and rising hospital numbers in China-39,000 units in 2024-drive the market. With the country’s population projected to stay above 1.39 billion until 2035 and 28% expected to be over 60 by 2040, healthcare demand is surging. Increasing government efforts to enhance the healthcare system and manage rising expenditures further support market growth.

Japan's catheter stabilization devices market dominated the Asia Pacific region in 2024, owing to a large patient pool, a growing target population, high unmet needs, and advanced infrastructure. Growing demand for various surgeries and increasing awareness are expected to boost market growth. Japan has over 8,000 hospitals and clinics, including public and private facilities. The government regulates nearly 60% of these facilities and is key in maintaining quality and accessibility.

Key Catheter Stabilization Devices Company Insights:

Some of the major companies in the catheter stabilization devices industry are BD; Baxter; 3M; and B. Braun Medical Inc. These companies stay competitive globally through continuous innovation, strategic partnerships, and expanding product portfolios. They invest in R&D to improve device safety and comfort, comply with international regulations, and tap into emerging markets. Leading players also focus on mergers and acquisitions to strengthen their market presence and meet the growing demand driven by the aging population and chronic diseases.

• BD is a medical technology company that develops innovative solutions to improve patient care. Its catheter stabilization devices enhance securement, reduce complications, and support clinical practices, ensuring greater safety, comfort, and efficiency in vascular access management across diverse healthcare settings.

• Baxter International Inc. is a healthcare company specializing in innovative medical products and therapies. Focusing on critical care, nutrition, renal, hospital, and surgical solutions, Baxter supports patients and clinicians by delivering life-saving treatments and advancing care in acute and chronic medical conditions.

Recent Developments

• In January 2025, B. Braun Medical Inc. launched the Clik-FIX Epidural/Peripheral Nerve Block Catheter Securement Device. The low-profile, soft, secure device minimizes catheter displacement and dislodgement during regional anesthesia, enhancing patient safety and pain control.

Catheter Stabilization Devices Market Report Scope

Global Catheter Stabilization Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global catheter stabilization devices market report based on product, end use, and region:

• Product Outlook (Revenue, USD Million; 2018 - 2030)

  • Arterial Securement Devices

  • CVC Securement Devices

  • Peripheral Securement Devices

  • Urinary Catheters Securement Devices

  • Chest Drainage Tubes Securement Devices

  • Others

• End Use Outlook (Revenue, USD Million; 2018 - 2030)

  • Hospitals

  • Home Healthcare Providers

  • Others

• Regional Outlook (Revenue, USD Million; 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait